R1	AND Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T5 Arg2:T6	
R3	Has_qualifier Arg1:T5 Arg2:T7	
R4	Has_qualifier Arg1:T5 Arg2:T8	
*	OR T9 T12 T11 T10
R5	Subsumes Arg1:T5 Arg2:T9	
R6	Has_value Arg1:T14 Arg2:T15	
R7	Has_value Arg1:T16 Arg2:T17	
R8	AND Arg1:T14 Arg2:T18	
R9	Has_qualifier Arg1:T20 Arg2:T21	
R10	Has_qualifier Arg1:T20 Arg2:T22	
R11	Has_index Arg1:T24 Arg2:T25	
R12	Subsumes Arg1:T23 Arg2:T26	
R13	AND Arg1:T20 Arg2:T23	
R14	Has_temporal Arg1:T20 Arg2:T24	
R15	Has_negation Arg1:T27 Arg2:T28	
R16	AND Arg1:T23 Arg2:T27	
*	OR T29 T30
R17	Has_temporal Arg1:T29 Arg2:T33	
R18	Has_mood Arg1:T29 Arg2:T32	
R19	AND Arg1:T29 Arg2:T31	
R20	Has_value Arg1:T36 Arg2:T37	
R21	Has_value Arg1:T39 Arg2:T40	
R22	Subsumes Arg1:T38 Arg2:T39	
R23	Subsumes Arg1:T35 Arg2:T36	
R24	Has_value Arg1:T42 Arg2:T43	
R25	Subsumes Arg1:T41 Arg2:T42	
*	OR T35 T38 T41
*	OR T46 T44
*	OR T45 T47 T48
R26	Has_index Arg1:T49 Arg2:T50	
R27	Has_temporal Arg1:T45 Arg2:T49	
R28	AND Arg1:T46 Arg2:T45	
R29	Has_mood Arg1:T53 Arg2:T54	
R30	Has_value Arg1:T55 Arg2:T56	
*	OR T58 T59 T60
R31	AND Arg1:T57 Arg2:T58	
R32	Has_temporal Arg1:T63 Arg2:T62	
R33	Has_index Arg1:T64 Arg2:T65	
*	OR T66 T67
R34	Has_index Arg1:T71 Arg2:T72	
R35	AND Arg1:T69 Arg2:T70	
R36	AND Arg1:T66 Arg2:T68	
*	OR T66 T69
R37	Has_temporal Arg1:T69 Arg2:T71	
R38	Has_value Arg1:T75 Arg2:T76	
*	OR T77 T78
R39	AND Arg1:T77 Arg2:T75	
R40	Has_qualifier Arg1:T74 Arg2:T80	
*	OR T74 T77
R41	Has_index Arg1:T81 Arg2:T82	
R42	Has_value Arg1:T83 Arg2:T84	
R43	Has_temporal Arg1:T87 Arg2:T88	
R44	Has_temporal Arg1:T87 Arg2:T89	
R45	Has_index Arg1:T89 Arg2:T90	
R46	AND Arg1:T92 Arg2:T93	
*	OR T91 T92
R47	AND Arg1:T16 Arg2:T18	
T1	Condition 42 106	heart team considers the patient to be a good surgical candidate
T2	Procedure 0 36	Heart Team assessment of operability
T3	Condition 125 152	acute myocardial infarction
T4	Temporal 153 202	= 1 month (30 days) before the intended treatment
T5	Condition 406 428	valvular heart disease
T6	Qualifier 395 405	left sided
T7	Qualifier 387 393	severe
T8	Qualifier 376 385	Untreated
T9	Condition 439 459	mitral regurgitation
T10	Condition 439 445;463 471	mitral stenosis
T11	Condition 477 497	aortic regurgitation
T12	Condition 477 483;501 509	aortic stenosis
T14	Measurement 512 543	Mean pulmonary artery pressures
T15	Value 544 551	=40mmHG
T16	Measurement 556 559	PVR
T17	Value 560 574	>4 woods units
T18	Condition 590 617	right heart catheterization
T20	Procedure 645 662	cardiac procedure
T21	Qualifier 636 644	invasive
T22	Qualifier 624 635	therapeutic
T23	Device 678 695	permanent implant
T24	Temporal 714 751	within 30 days of the index procedure
T25	Reference_point 732 751	the index procedure
T26	Device 805 816	heart valve
T27	Device 836 855	permanent pacemaker
T28	Negation 859 867	excluded
T29	Procedure 904 912;930 938	surgical ablation
T30	Procedure 916 938	transcatheter ablation
T31	Condition 943 962	Atrial Fibrillation
T32	Mood 884 891	planned
T33	Temporal 892 903	concomitant
T35	Condition 965 975	Leukopenia
T36	Measurement 977 980	WBC
T37	Value 981 995	< 3000 cell/mL
T38	Condition 998 1010	acute anemia
T39	Measurement 1012 1015	Hgb
T40	Value 1016 1024	< 9 g/dL
T41	Condition 1027 1043	Thrombocytopenia
T42	Measurement 1045 1048	Plt
T43	Value 1049 1065	< 50,000 cell/mL
T44	Condition 1084 1107	respiratory instability
T45	Procedure 1118 1135	inotropic support
T46	Condition 1069 1080;1096 1107	Hemodynamic instability
T47	Procedure 1137 1159	mechanical ventilation
T48	Procedure 1163 1190	mechanical heart assistance
T49	Temporal 1191 1229	within 30 days of screening evaluation
T50	Reference_point 1209 1229	screening evaluation
T53	Procedure 1241 1258	emergency surgery
T54	Mood 1232 1240	Need for
T55	Measurement 1276 1310	Left ventricular ejection fraction
T56	Value 1311 1315	<40%
T57	Procedure 1318 1335	Echocardiographic
T58	Condition 1348 1365	intracardiac mass
T59	Condition 1348 1360;1367 1375	intracardiac thrombus
T60	Condition 1348 1360;1379 1389	intracardiac vegetation
T62	Temporal 1392 1398	Active
T63	Condition 1399 1416	upper GI bleeding
T64	Temporal 1417 1461	within 3 months (90 days) prior to procedure
T65	Reference_point 1452 1461	procedure
T66	Condition 1472 1488	contraindication
T67	Condition 1492 1508	hypersensitivity
T68	Procedure 1516 1540	anticoagulation regimens
T69	Condition 1545 1554	inability
T70	Procedure 1561 1575	anticoagulated
T71	Temporal 1576 1599	for the study procedure
T72	Reference_point 1584 1599	study procedure
T74	Condition 1609 1612	CVA
T75	Procedure 1654 1666	neuroimaging
T76	Value 1667 1676	confirmed
T77	Condition 1677 1683	stroke
T78	Condition 1687 1718	transient ischemic attack (TIA)
T80	Qualifier 1613 1650	clinically confirmed (by neurologist)
T81	Temporal 1719 1762	within 6 months (180 days) of the procedure
T82	Reference_point 1749 1762	the procedure
T83	Observation 1765 1790	Estimated life expectancy
T84	Value 1791 1799	< 1 year
T85	Non-query-able 1832 1918	Expectation that patient will not improve despite treatment of tricuspid regurgitation
T86	Non-query-able 1920 2221	Currently participating in another investigational cardiac device study or any other clinical trial, including drugs or biologics. Note: Trials requiring extended follow-up for products that were investigational, but have since become commercially available, are not considered investigational trials.
T87	Condition 2230 2252	bacterial endocarditis
T88	Temporal 2223 2229	Active
T89	Temporal 2253 2292	within 6 months (180 days) of procedure
T90	Reference_point 2280 2292	of procedure
T91	Condition 2330 2342	SVC syndrome
T92	Condition 2347 2364	hepatic cirrhosis
T93	Condition 2381 2407	passive congestion from TR
